However, their usage may vary depending on specific patient needs and conditions: Ipamorelin: Known for its ability to stimulate growth hormone release without significantly increasing levels of other hormones like cortisol and prolactin, potentially leading to fewer side effects
Hori M, Hasegawa Y, Hayashi Y, Nakagami T, Harada-Shiba M
Cvorovic J, Tramer F, Granzotto M, Candussio L, Decorti G, Passamonti S
doi: 10.3389/fnut.2022.1007816 Received 31 July 2022 Accepted 12 October 2022 Published 01 November 2022 Volume 9 - 2022 Edited by Yannan Jin, De Montfort University, United Kingdom Reviewed by Mostafa Waly, Sultan Qaboos University, Oman
10.1007/s11883-018-0737-7 Curr Atheroscler Rep
At present, the primary approach to treat patients with CCA remains rooted in surgical interventions, and the prognosis for patients ineligible for surgery is poor (103)